Back to Search
Start Over
Cellular immunotherapy for refractory hematological malignancies
- Source :
- Journal of Clinical Oncology. 33:7039-7039
- Publication Year :
- 2015
- Publisher :
- American Society of Clinical Oncology (ASCO), 2015.
-
Abstract
- 7039 Background: Allogeneic cellular infusion is a potent immune stimulus. We present data from our FDA approved IND Phase II clinical trial (BrUOG 273) where allogeneic haploidentical lymphocytes ...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........91e18731a5208264b830cf2dd45503c0
- Full Text :
- https://doi.org/10.1200/jco.2015.33.15_suppl.7039